$95.00
CJC-1295 with DAC is a synthetic analog of growth hormone–releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) to extend plasma stability and receptor interaction duration in experimental models. It binds to GHRH receptors and is studied for its role in somatotropic axis modulation and growth hormone regulatory signaling. Preclinical research utilizes CJC-1295 with DAC to investigate prolonged receptor activation kinetics, downstream intracellular signaling cascades, and peptide-mediated endocrine pathway regulation under controlled laboratory conditions.
For research use only. Not for human consumption.
References:
Teichman SL et al., J Clin Endocrinol Metab, 2006
Vance ML et al., Metabolism, 1985
Bowers CY et al., Endocrinology, 1980
CJC-1295 with DAC is a modified GHRH analog widely studied in laboratory research focused on growth hormone signaling and somatotropic axis regulation. The inclusion of a Drug Affinity Complex enhances peptide stability and extends receptor interaction duration in experimental systems.
Biochemical Characteristics
CJC-1295 with DAC retains the active GHRH sequence while incorporating a Drug Affinity Complex that allows covalent binding to circulating albumin. This modification increases peptide half-life and supports sustained receptor engagement in controlled laboratory studies.
Research Applications
CJC-1295 with DAC is utilized in research models investigating growth hormone regulation, receptor activation kinetics, peptide stability, and extended endocrine signaling dynamics.
Pathway / Mechanistic Context
Mechanistic research focuses on GHRH receptor activation and downstream JAK-STAT signaling cascades associated with growth hormone synthesis and release, with emphasis on prolonged pathway modulation due to DAC incorporation.
Preclinical Research Summary
Preclinical investigations have evaluated CJC-1295 with DAC in in vitro and experimental models to better understand sustained receptor-mediated endocrine signaling and growth hormone pathway dynamics.
Form & Analytical Testing
CJC-1295 with DAC is supplied as a lyophilized peptide and undergoes analytical verification, including HPLC testing, to confirm identity, purity, and composition consistency for laboratory research use.
RUO Disclaimer
This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.
Reviews
There are no reviews yet.